GTE-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GTE-001, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma [Phase 1]